相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
Qutuba G. Karwi et al.
CARDIOVASCULAR RESEARCH (2022)
The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy
Fadumo Ahmed Isse et al.
DRUG METABOLISM REVIEWS (2022)
RNA Sequencing of Cardiac in a Rat Model Uncovers Potential Target LncRNA of Diabetic Cardiomyopathy
Yangbo Xi et al.
FRONTIERS IN GENETICS (2022)
Roles of Ferroptosis in Cardiovascular Diseases
Yuting Guo et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
SFRP2 Improves Mitochondrial Dynamics and Mitochondrial Biogenesis, Oxidative Stress, and Apoptosis in Diabetic Cardiomyopathy
Tianyi Ma et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Prediabetes and the risk of heart failure: A meta-analysis
Xiaoyan Cai et al.
DIABETES OBESITY & METABOLISM (2021)
The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity
Qutuba G. Karwi et al.
CELLS (2021)
Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms
Haoxiao Zheng et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Association between prediabetes and adverse outcomes in heart failure
Linlin Mai et al.
DIABETES OBESITY & METABOLISM (2021)
Cardiomyopathy in obesity, insulin resistance and diabetes
Michinari Nakamura et al.
JOURNAL OF PHYSIOLOGY-LONDON (2020)
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors JACC State-of-the-Art Review
Thomas A. Zelniker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Yi Tan et al.
NATURE REVIEWS CARDIOLOGY (2020)
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study
Yongze Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat
Yebin Xie et al.
FRONTIERS IN PHYSIOLOGY (2020)
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Martin R. Cowie et al.
NATURE REVIEWS CARDIOLOGY (2020)
Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy
Vajir Malek et al.
CARDIOVASCULAR RESEARCH (2019)
Diabetic Cardiomyopathy What Is It and Can It Be Fixed?
Wolfgang H. Dillmann
CIRCULATION RESEARCH (2019)
SGLT2 Inhibition Changing What Fuels the Heart
Michael Lehrke
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
Carlos G. Santos-Gallego et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Guanghong Jia et al.
CIRCULATION RESEARCH (2018)
Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review
Eylem Levelt et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy
Thomas H. Marwick et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data
Edward W. Gregg et al.
LANCET (2018)
Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis
Junlian Gu et al.
CELL DEATH & DISEASE (2018)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
Gregory A. Roth et al.
LANCET (2018)
Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
Laween Uthman et al.
FRONTIERS IN PHYSIOLOGY (2018)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes
Eylem Levelt et al.
DIABETES (2016)
Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism
Francois Briand et al.
DIABETES (2016)
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Heidi Storgaard et al.
PLOS ONE (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Myocardial Contractile Dysfunction Is Associated With Impaired Mitochondrial Function and Dynamics in Type 2 Diabetic but Not in Obese Patients
David Montaigne et al.
CIRCULATION (2014)
Identification and Confirmation of Differentially Expressed Fucosylated Glycoproteins in the Serum of Ovarian Cancer Patients Using a Lectin Array and LC-MS/MS
Jing Wu et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
Warwick B. Dunn et al.
NATURE PROTOCOLS (2011)
Global metabolic profiling procedures for urine using UPLC-MS
Elizabeth J. Want et al.
NATURE PROTOCOLS (2010)
Universal sample preparation method for proteome analysis
Jacek R. Wisniewski et al.
NATURE METHODS (2009)
Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in Rats
Beshay N. M. Zordoky et al.
DRUG METABOLISM AND DISPOSITION (2008)
分享论文
